13 results about "Alcohol consumption" patented technology

1. The name of the design product: label (alcoholic beverage). 2. The use of the design product: label for sticking on the packaging cans, boxes, bottles. 3. The design points of the design product: the combination of shape and pattern. 4. The picture or photo that best indicates the design points: perspective view. 5. The design product is a flat product, omitting the left view, right view, top view, bottom view.

Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non- alcoholic fatty liver disease (NAFLD), is a condition characterized by the accumulation of fat in the liver of individuals with no alcohol consumption, and at least one cardiometabolic risk factor (overweight / obesity, high blood pressure, high blood sugar, high triglycerides levels, low HDL-C levels). The inventors demonstrated that Rab30 silencing improve metabolic dysfunction–associated steatotic liver disease (MASLD). The present invention relates to a method for the treatment of metabolic dysfunction–associated steatotic liver disease (MASLD) in a subject in need thereof comprising the administration of a therapeutically effective amount of an inhibitor of Rab30.

An object of a system according to an embodiment is to provide appropriate advice for preventing excessive drinking based on a health condition and a physical constitution of a drinker.SOLUTION: A system includes a constitution acquisition part, a health condition collection part, a drinking data collection part, an advice provision part, and a physical condition check part. The physical constitution acquisition unit acquires a physical constitution of a drinker to alcohol. The health condition collection unit collects a health condition of today. The drinking data collection unit collects types and amounts of alcohol to be drunk. The advice providing unit gives advice when taking the next cup. The physical condition check unit checks a physical condition in cooperation with a watch device.SELECTED DRAWING: Figure 1

The invention relates to a dihydromyricetin derivative (1,2), wherein the dihydromyricetin derivative (1,2) is edible and water-soluble and, when completely dissolved in a liquid, is unpolymerized, and to a composition containing the dihydromyricetin derivative (1,2). Furthermore, the invention relates to the use of the dihydromyricetin derivative (1,2) or the composition as an anti-hangover additive for a food and / or a pharmaceutical product for the relief, prevention, and / or treatment of hangover symptoms caused by alcohol consumption and / or for accelerating the breakdown and metabolism of alcohol.The invention further relates to a process for producing a dihydromyricetin derivative (1, 2) that is edible and water-soluble and, when completely dissolved in a liquid, is unpolymerized, comprising modifying (3) dihydromyricetin to obtain the edible, water-soluble dihydromyricetin derivative (1, 2) that, when completely dissolved in a liquid, is unpolymerized. The invention further relates to a process for maintaining the long-term solubility of the DHM derivative in aqueous solutions and preventing crystallization by adding 35-45% vol alcohol as well as essential oils or flavorings. These additional components ensure that the DHM derivative remains dissolved and stable for extended periods, making the solution suitable for use in various products such as foods, dietary supplements, and pharmaceuticals.

The utility model provides a volume-controllable wine cup. The volume-controllable wine cup comprises a cup body, a cup cover, a motor and a circuit board, a control switch is arranged on the outer side of the cup body, and a partition plate is arranged on the lower portion of the cup body. The cup cover is rotationally connected to a cup opening of the cup body and can cover the cup opening after being turned downwards. The motor is installed on the outer side of the upper end of the cup body and used for driving the cup cover to rotate. The circuit board is arranged in the cup body below the partition plate and is provided with a single chip microcomputer, a clock chip and a memory, the liquid level sensor is used for measuring the drinking amount of each time, the clock chip is used for timing, the single chip microcomputer is used for counting drinking amount data in unit time, the memory is used for storing data, and the control switch is used for sending a starting instruction to the single chip microcomputer after being pressed. The single-chip microcomputer starts the motor to open the cup cover when receiving the starting instruction and the drinking amount data is smaller than a preset value. According to the invention, the drinking amount in a period of time can be counted to limit excessive drinking.

This invention discloses a clear, stable, and low-irritant plant-based compound beverage, its preparation method, and its application. The beverage is formed by the in-situ self-assembly of polyphenol-containing plant extracts and small-molecule food-derived oligopeptides in an aqueous solution, creating nano-complex particles with an average particle size of 80–200 nm, a Zeta potential of -25 to -40 mV, and a PDI ≤ 0.3. It contains no added exogenous stabilizers, thickeners, flavoring agents, fragrances, or colorings. After 30 days of accelerated clarification at 37°C, no precipitation occurs, with a turbidity ≤ 5 NTU and a light transmittance ≥ 90%, effectively masking bitter and spicy irritations. The plant extracts are a compound of kudzu root, Japanese raisin tree fruit, chrysanthemum, poria cocos, monk fruit, ginger, and yam, with a polyphenol to oligopeptide mass ratio of 3:4. The product can relieve dry mouth and throat discomfort caused by alcohol consumption, staying up late, and smoking. The process is simple and suitable for industrial production.

The invention relates to the field of medical biology, in particular to a biological preparation for inhibiting the alcohol drinking amount of an alcohol-dependent person and application of the biological preparation. The invention discloses a biological agent for inhibiting the alcohol drinking amount of an alcohol-dependent person. The biological agent is lactobacillus plantarum extracellular vesicles. The lactobacillus plantarum extracellular vesicles play a role in regulating and controlling the drinking amount of alcohol-dependent rats by regulating the expression of the BNDF, the lactobacillus plantarum extracellular vesicles can increase the expression of the BDNF of PC12 cells in an in-vitro cell culture experiment, alcohol reduces the expression of the BDNF of the PC12 cells, and the lactobacillus plantarum extracellular vesicles achieve the inhibition effect by reversing the expression of the alcohol on the BDNF of the PC12 cells. According to the biological preparation for inhibiting the alcohol drinking amount of the alcohol-dependent person and the application of the biological preparation, SD male rats serve as research objects, the inhibiting effect of extracellular vesicles derived from intestinal lactobacillus plantarum on the alcohol drinking amount of the alcohol-dependent rats and related mechanisms are researched, and a new thought is provided for clinical prevention and treatment of alcohol dependence.

This invention discloses a compound probiotic composition, its preparation method, and its applications. The compound probiotic composition comprises compound probiotics and compound compounds, wherein the components exert a synergistic effect in the body, significantly shortening the righting reflex recovery time after alcohol intake, effectively alleviating the physiological burden caused by alcohol consumption, and reducing alcohol-induced liver oxidative stress and lipid peroxidation levels. In other words, the compound probiotic composition has a hangover-relieving and liver-protecting effect. Furthermore, the compound probiotic composition helps improve and maintain the homeostasis of the gut-liver axis in alcohol- or non-alcohol-related sub-health states (such as sleep disorders), improving liver damage, regulating gut microbiota structure, and improving intestinal barrier damage. It is suitable for individuals requiring liver function regulation and nutritional intervention.

This disclosure relates to methods for treating alcohol use disorder by administering to a human subject in need a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. In certain embodiments, the compound is a compound of formula (II), (IIA), (IIB), or (IIC), or a solvate thereof, and is administered in a dose of from about 0.10 mg to about 10.0 mg. The disclosure also provides methods of preventing relapse to alcohol drinking, for reducing alcohol consumption, for decreasing alcohol craving, for maintenance of alcohol abstinence, for treating or preventing withdrawal from alcohol consumption, treating alcohol-related sleep disorder, and / or for reducing stress or anxiety level in a human subject.

An alcohol amount management system (1) for managing the amount of alcohol consumed by a user causes a computer to function to: set the user's tolerance for alcohol consumption; acquire consumption information indicating the user's alcohol consumption status; on the basis of the tolerance and the consumption information, set an appropriate value for the amount of alcohol to be included in an alcoholic beverage that is to be consumed by the user such that the user does not consume alcohol beyond an appropriate range corresponding to the tolerance; and output the set appropriate value.

The invention provides an alcohol consumption and cooling capacity correlation prediction method in a nickel sheet stamping process, which comprises the following steps: extracting a temperature difference between a nickel sheet surface temperature value and an alcohol initial contact temperature value according to a temperature acquisition record, carrying out temperature difference superposition on continuous acquisition point locations, and determining an interface temperature difference total value; the maximum temperature difference in the interface temperature difference cumulant is analyzed, the value of the maximum temperature difference compared with the film boiling trigger temperature is evaluated, and a boiling trigger mark and a current stamping stage number are obtained; cooling heat exchange mode classification recognition is conducted on the boiling trigger marks, the stamping stage numbers and historical stamping stage data through a support vector machine algorithm, and the boiling critical temperature difference of each stamping process stage is obtained; based on the alcohol spraying amount adjustment amplitude, the steam interlayer formation risk is evaluated, an alcohol spraying amount reduction value is obtained, and a spraying control signal is generated and sent to the adjustment module.

This utility model relates to an alcohol waste liquid treatment device. The device includes: a dilution container; the dilution container storing a diluent; an alcohol waste liquid conveying assembly connected to the inlet of the dilution container; a gas conveying pipe connected to the outlet of the dilution container; and a filter assembly installed on the gas conveying pipe. The alcohol waste liquid is introduced into the dilution container through the alcohol waste liquid conveying assembly; the filter assembly filters the volatile gas-liquid mixture in the dilution container to obtain alcohol gas; and the alcohol gas is discharged through the gas conveying pipe. This device effectively reduces the treatment cost and construction complexity of alcohol waste liquid, improves the safety of alcohol waste liquid recycling, and is better suited for production scenarios with small alcohol consumption.